The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback